Key result
Transcutaneous vagus nerve stimulation did not demonstrate significant clinical effects on generalized anxiety disorder, irritable bowel syndrome, or chronic pain in a small-scale uncontrolled study.
Why the study?
Generalized anxiety disorder, chronic pain, and irritable bowel syndrome are debilitating inflammatory disorders frequently seen in primary care but not sufficiently addressed by classical medical treatments.
Does transcutaneous vagus nerve stimulation improve symptoms in patients with generalized anxiety disorder, chronic pain, or irritable bowel syndrome?
Does transcutaneous vagus nerve stimulation improve symptoms in patients with generalized anxiety disorder, chronic pain, or irritable bowel syndrome?
In a small, uncontrolled study, transcutaneous vagus nerve stimulation was well-tolerated and showed non-significant trends toward symptom improvement in anxiety and IBS, but not chronic pain.
Answers are grounded in this paper and cite their sources.
No support for transcutaneous vagus nerve stimulation in these conditions; leaves open efficacy in controlled trials.
Generalized anxiety disorder (GAD), chronic pain (CP) and irritable bowel syndrome (IBS) are debilitating inflammatory disorders that are frequently seen in primary care facilities but not sufficiently addressed by classical medical treatments
No takes yet. Share an insight, caveat, or question.
Pascal J. Grolaux (2019) studied Generalized anxiety disorder, chronic pain, and irritable bowel syndrome (n=10). Transcutaneous vagus nerve stimulation (tVNS) was evaluated on Clinical improvement on GAD, CP, and IBS using GAD-7, BPI, and IBS-SSS questionnaires. Transcutaneous vagus nerve stimulation did not demonstrate significant clinical effects on generalized anxiety disorder, irritable bowel syndrome, or chronic pain in a small-scale uncontrolled study.
Synapse has enriched 10 related papers. Consider them for comparative context: